Cystic fibrosis liver disease
Clinical trials for Cystic fibrosis liver disease explained in plain language.
Never miss a new study
Get alerted when new Cystic fibrosis liver disease trials appear
Sign up with your email to follow new studies for Cystic fibrosis liver disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple therapy under the microscope: does it transform cystic fibrosis care?
Disease control OngoingResearchers are observing how elexacaftor/tezacaftor/ivacaftor triple combination therapy affects people with cystic fibrosis in routine care. The study follows two groups: children aged 6 to 11 and people aged 12 and older. Over seven years, they measure lung function, inflammat…
Matched conditions: CYSTIC FIBROSIS LIVER DISEASE
Phase 4 • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Scientists hunt for genes behind liver disease in cystic fibrosis
Knowledge-focused OngoingThis study looks at genes, other than the CF gene, that might explain why some people with cystic fibrosis develop severe liver disease while others do not. Researchers are analyzing blood samples and medical records from 154 participants with CF who have serious liver problems. …
Matched conditions: CYSTIC FIBROSIS LIVER DISEASE
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC